What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
Main Author: | Peter Wiedemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2022-09-01
|
Series: | International Journal of Ophthalmology |
Online Access: | http://ies.ijo.cn/en_publish/2022/9/20220901.pdf |
Similar Items
-
Proliferative vitreoretinopathy
by: Mojca Globočnik-Petrovič, et al.
Published: (2005-10-01) -
Results of retinotomy for retinal detachment with marked proliferative vitreoretinopathy
by: I. Ia. Novytskyy, et al.
Published: (2020-10-01) -
Proliferative Vitreoretinopathy: A Reappraisal
by: Paolo Carpineto, et al.
Published: (2023-08-01) -
Proliferative Vitreoretinopathy and Genetic Profile
by: Khalil Ghasemi Falavarjani
Published: (2013-01-01) -
The impact of octreotide in experimental proliferative vitreoretinopathy
by: Ozge Evren, et al.
Published: (2013-01-01)